A 53-year-old woman undergoes emergency laparotomy for perforated diverticulitis. She received intravenous co-amoxiclav 1.2g and metronidazole 500mg at induction of anaesthesia at 14:00. The operation was completed at 17:30. Post-operatively she remains on the surgical ward, is haemodynamically stable, and is receiving intravenous fluids. According to current UK antimicrobial stewardship guidance on surgical prophylaxis, what is the most appropriate antibiotic management?
Q52
A 67-year-old man with chronic venous insufficiency and recurrent cellulitis presents with his fourth episode in 14 months affecting the right lower leg. Each episode has required hospital admission and intravenous antibiotics. He has been treated for venous eczema and uses compression stockings irregularly. BMI is 32 kg/m². He has type 2 diabetes with HbA1c of 64 mmol/mol. Interdigital tinea pedis is noted on examination. Which intervention is most likely to reduce future episodes of cellulitis?
Q53
According to the UK 'Start Smart - Then Focus' antimicrobial stewardship toolkit, which of the following scenarios constitutes an appropriate indication for NOT performing the 'Senior Review' at 48-72 hours?
Q54
A 42-year-old man who works as a sous chef presents with a 5-day history of a progressively enlarging, painful swelling on his right index finger. The paronychia was initially treated with oral flucloxacillin by his GP 3 days ago with no improvement. On examination, there is marked erythema, swelling of the entire finger extending to the proximal interphalangeal joint, with a small area of purulent discharge at the nail fold. He is systemically well. Which organism is most likely responsible for the treatment failure?
Q55
A hospital antimicrobial stewardship committee reviews consumption data showing that use of carbapenems has increased by 35% over 12 months, while microbiological culture rates have remained static. An audit of 50 carbapenem prescriptions reveals that 26 were started empirically in the Emergency Department, 12 were continued from ICU step-down without review, and 12 were prescribed following positive culture results. Which intervention is most likely to reduce inappropriate carbapenem use?
Q56
A 58-year-old woman presents to the Emergency Department with a 30-hour history of a painful, swollen, erythematous right calf. She has type 2 diabetes treated with metformin. Temperature is 38.2°C, heart rate 98 bpm, blood pressure 135/82 mmHg. The affected area measures 18 cm × 12 cm with a clearly demarcated edge and is tender to touch. There is no crepitus, no blistering, and no systemic signs of sepsis. Blood tests show WCC 13.2 × 10⁹/L, CRP 78 mg/L, creatinine 82 μmol/L. What is the most appropriate antibiotic choice?
Q57
A hospital trust implements a new antimicrobial stewardship initiative using intravenous-to-oral switch protocols for patients on IV antibiotics who meet specific criteria: afebrile for 24 hours, improving clinically, able to swallow, and functioning gastrointestinal tract. After 6 months, audit data shows that the median duration of IV therapy has decreased from 5.5 days to 3.2 days, with no increase in treatment failures or readmissions. What is the primary benefit of this intervention in terms of antimicrobial stewardship principles?
Q58
A 33-year-old woman who keeps pet reptiles presents with a 5-day history of multiple painful nodules on her shins that have not ulcerated. She also reports fever, malaise, and joint pains. The nodules are tender, erythematous, raised, and located on the anterior shins bilaterally without ulceration. What is the most likely diagnosis and appropriate initial investigation?
Q59
A hospital antimicrobial stewardship committee is reviewing strategies to reduce healthcare-associated Clostridioides difficile infections (CDI), which have increased by 30% over the past year. Analysis shows that most cases follow treatment with broad-spectrum antibiotics, particularly co-amoxiclav, cephalosporins, and fluoroquinolones. Which of the following interventions would most effectively reduce CDI incidence based on current evidence?
Q60
A 69-year-old man with compensated liver cirrhosis (Child-Pugh B) due to alcohol-related liver disease presents with a 2-day history of a painful, rapidly spreading erythematous rash on his right leg after paddling in seawater at the beach. Examination reveals a haemorrhagic bullous cellulitis extending from ankle to knee. Temperature is 38.9°C, BP 108/68 mmHg, and heart rate 102 bpm. Which pathogen is most likely responsible and what is the appropriate antibiotic therapy?
Common Infections UK Medical PG Practice Questions and MCQs
Question 51: A 53-year-old woman undergoes emergency laparotomy for perforated diverticulitis. She received intravenous co-amoxiclav 1.2g and metronidazole 500mg at induction of anaesthesia at 14:00. The operation was completed at 17:30. Post-operatively she remains on the surgical ward, is haemodynamically stable, and is receiving intravenous fluids. According to current UK antimicrobial stewardship guidance on surgical prophylaxis, what is the most appropriate antibiotic management?
A. Continue co-amoxiclav and metronidazole intravenously for 5 days (Correct Answer)
B. Give one further dose of co-amoxiclav and metronidazole then stop
C. Stop all antibiotics immediately as prophylaxis is complete
D. Continue co-amoxiclav and metronidazole for 24 hours post-operatively then stop
E. Switch to oral co-amoxiclav and metronidazole for 5 days
Explanation: ***Continue co-amoxiclav and metronidazole intravenously for 5 days***- This patient has **perforated diverticulitis**, which represents an **established intra-abdominal infection** (peritonitis) rather than a simple case requiring only surgical prophylaxis.- Current **antimicrobial stewardship** guidelines specify that when established infection or perforation is encountered, a **therapeutic course** (typically 5 days) is required instead of single-dose prophylaxis.*Give one further dose of co-amoxiclav and metronidazole then stop*- Extending prophylaxis by a single dose is generally not recommended in modern guidelines; prophylaxis should ideally be a **single preoperative dose**.- This approach is insufficient here because the surgery confirmed a **perforation**, which necessitates a full treatment course to manage bacterial contamination.*Stop all antibiotics immediately as prophylaxis is complete*- While **surgical prophylaxis** for clean-contaminated cases should ideally be a single dose, this rule does not apply to **therapeutic treatment** of active infections.- Stopping immediately after surgery for a perforation would carry a high risk of **treatment failure** and postoperative abscess formation.*Continue co-amoxiclav and metronidazole for 24 hours post-operatively then stop*- A **24-hour limit** is often the maximum duration for prophylaxis in prolonged or complex surgeries, but it is not intended for cases with **gross fecal contamination**.- Perforated diverticulitis requires a longer duration of antibiotics to ensure the **inflammatory process** and bacterial load are adequately controlled.*Switch to oral co-amoxiclav and metronidazole for 5 days*- While an **IV-to-oral switch** is a key stewardship principle, it is usually only appropriate once the patient is **clinically improving**, afebrile, and tolerating oral intake.- Immediately post-laparotomy for perforation, the patient is likely to have an **ileus** or restricted oral intake, making intravenous administration the more reliable route initially.
Question 52: A 67-year-old man with chronic venous insufficiency and recurrent cellulitis presents with his fourth episode in 14 months affecting the right lower leg. Each episode has required hospital admission and intravenous antibiotics. He has been treated for venous eczema and uses compression stockings irregularly. BMI is 32 kg/m². He has type 2 diabetes with HbA1c of 64 mmol/mol. Interdigital tinea pedis is noted on examination. Which intervention is most likely to reduce future episodes of cellulitis?
A. Prophylactic oral phenoxymethylpenicillin 500mg once daily
B. Ensuring optimal diabetes control and treating tinea pedis with topical antifungal therapy (Correct Answer)
C. Prescribing prophylactic flucloxacillin 500mg twice daily
D. Arranging elective saphenofemoral junction ligation surgery
E. Prescribing long-term oral doxycycline 100mg daily
Explanation: ***Ensuring optimal diabetes control and treating tinea pedis with topical antifungal therapy***- Addressing **modifiable risk factors** and portal of entry (like **tinea pedis**) is the primary step in preventing recurrent cellulitis.- Managing **blood glucose levels** and skin integrity significantly reduces the risk of bacterial invasion before considering long-term antibiotic prophylaxis.*Prophylactic oral phenoxymethylpenicillin 500mg once daily*- Guidelines recommend **antibiotic prophylaxis** only after all other predisposing factors have been optimized.- While it can be used for recurrent episodes, it is not the first-line intervention when active **tinea pedis** and poorly controlled **diabetes** are present.*Prescribing prophylactic flucloxacillin 500mg twice daily*- **Flucloxacillin** is typically used for acute treatment of staph infections but is not the preferred agent for long-term **streptococcal prophylaxis**.- It has a higher side-effect profile regarding **gastrointestinal tolerance** compared to phenoxymethylpenicillin.*Arranging elective saphenofemoral junction ligation surgery*- While venous insufficiency is a risk factor, **surgical ligation** is not an established primary prevention strategy for recurrent cellulitis.- Conservative management of venous disease with **compression stockings** and weight loss is prioritized over surgical intervention in this context.*Prescribing long-term oral doxycycline 100mg daily*- **Tetracyclines** are not the first-choice antibiotics for the prophylaxis of **Group A Streptococcus**, the most common cause of cellulitis.- This approach does not address the **underlying skin breaches** or metabolic factors contributing to the patient's recurrent infections.
Question 53: According to the UK 'Start Smart - Then Focus' antimicrobial stewardship toolkit, which of the following scenarios constitutes an appropriate indication for NOT performing the 'Senior Review' at 48-72 hours?
A. A patient on oral antibiotics for uncomplicated lower urinary tract infection being managed in the community (Correct Answer)
B. A patient receiving intravenous meropenem for hospital-acquired pneumonia on a general medical ward
C. A patient on oral co-amoxiclav for cellulitis admitted under the acute medical unit
D. A patient receiving intravenous vancomycin for suspected endocarditis under the cardiology team
E. A neutropenic patient receiving empirical piperacillin-tazobactam on the haematology ward
Explanation: ***A patient on oral antibiotics for uncomplicated lower urinary tract infection being managed in the community***
- The **'Start Smart - Then Focus'** toolkit is specifically designed for **secondary care (hospital)** settings to ensure antimicrobial stewardship during inpatient stays.
- **Community-managed cases** follow primary care guidelines and do not mandate the formal 48-72 hour **clinical review** required for all hospital antibiotic prescriptions.
*A patient receiving intravenous meropenem for hospital-acquired pneumonia on a general medical ward*
- All **hospital inpatients** initiated on antibiotics must have a **Senior Review** at 48-72 hours to decide on stopping, switching, or narrowing therapy.
- Broad-spectrum agents like **meropenem** specifically require documented stewardship decisions to prevent the development of **antimicrobial resistance**.
*A patient on oral co-amoxiclav for cellulitis admitted under the acute medical unit*
- The requirement for a **48-72 hour review** applies to **all antibiotics** in a hospital setting, regardless of whether the route is **intravenous or oral**.
- This review ensures that the initial **empirical diagnosis** is still valid and determines if a definite **stop date** can be established.
*A patient receiving intravenous vancomycin for suspected endocarditis under the cardiology team*
- **Complex infections** such as endocarditis require rigorous oversight to review **microbiology results** and clinical response at the 72-hour mark.
- The toolkit mandates that a **clear clinical plan** (Stop, Switch, Change, or Continue) is documented for every inpatient by a senior clinician.
*A neutropenic patient receiving empirical piperacillin-tazobactam on the haematology ward*
- High-risk patients on **broad-spectrum empiric therapy** must be reviewed to check for **de-escalation** opportunities based on culture results.
- Failure to perform a **Senior Review** in this scenario would be a breach of the **antimicrobial stewardship** standards defined by the UK Health Security Agency.
Question 54: A 42-year-old man who works as a sous chef presents with a 5-day history of a progressively enlarging, painful swelling on his right index finger. The paronychia was initially treated with oral flucloxacillin by his GP 3 days ago with no improvement. On examination, there is marked erythema, swelling of the entire finger extending to the proximal interphalangeal joint, with a small area of purulent discharge at the nail fold. He is systemically well. Which organism is most likely responsible for the treatment failure?
A. Methicillin-resistant Staphylococcus aureus
B. Streptococcus pyogenes
C. Candida albicans (Correct Answer)
D. Eikenella corrodens
E. Pasteurella multocida
Explanation: ***Candida albicans***
- The patient's occupation as a **sous chef** involves frequent **wet work**, a well-established risk factor for **chronic paronychia** caused by **Candida albicans**.
- Failure of symptoms to improve after 3 days of **oral flucloxacillin** (an antibacterial) strongly suggests a non-bacterial etiology, making a fungal infection the most probable cause.
*Methicillin-resistant Staphylococcus aureus*
- While **MRSA** would not respond to flucloxacillin, the patient's occupational exposure to moisture makes **fungal infection** a more likely primary diagnosis for this paronychia.
- **MRSA** often presents with more severe or acute local infections, and less typically as a progressively chronic paronychia in this specific occupational setting.
*Streptococcus pyogenes*
- **Streptococcus pyogenes** is generally highly susceptible to **flucloxacillin**; therefore, treatment failure makes this organism an unlikely cause.
- An infection by this bacterium would typically show signs of improvement rather than progression after appropriate antibiotic therapy.
*Eikenella corrodens*
- **Eikenella corrodens** is typically associated with infections resulting from **human bites** or **clenched-fist injuries**.
- There is no history in the patient's presentation to suggest such an exposure, making this pathogen improbable.
*Pasteurella multocida*
- This organism is a common cause of infection following **animal bites**, particularly from **cats or dogs**.
- The clinical context lacks any history of animal contact or bites, ruling out **Pasteurella multocida** as the likely pathogen.
Question 55: A hospital antimicrobial stewardship committee reviews consumption data showing that use of carbapenems has increased by 35% over 12 months, while microbiological culture rates have remained static. An audit of 50 carbapenem prescriptions reveals that 26 were started empirically in the Emergency Department, 12 were continued from ICU step-down without review, and 12 were prescribed following positive culture results. Which intervention is most likely to reduce inappropriate carbapenem use?
A. Implementing an automatic 72-hour stop order for all carbapenem prescriptions
B. Requiring microbiology approval for all carbapenem prescriptions before dispensing
C. Introducing a mandatory antimicrobial ward round review at 48-72 hours (Correct Answer)
D. Removing carbapenems from the hospital formulary
E. Implementing educational sessions on carbapenem indications for Emergency Department staff
Explanation: ***Introducing a mandatory antimicrobial ward round review at 48-72 hours***
- This intervention directly addresses the 76% of inappropriate carbapenem use identified, covering both **empirical starts** and **unreviewed continuations** from ICU step-down.
- A mandatory review allows for timely **de-escalation** or discontinuation of broad-spectrum therapy based on **microbiological culture results** and clinical status, aligning with best **antimicrobial stewardship** practices.
*Implementing an automatic 72-hour stop order for all carbapenem prescriptions*
- An **automatic stop order** without clinical review can be dangerous, risking **premature cessation** of critical treatment for patients who still require carbapenems for severe or **multi-drug resistant infections**.
- This approach fails to provide a mechanism for **therapy optimization** or **alternative antibiotic selection**, potentially compromising patient safety and promoting treatment failure.
*Requiring microbiology approval for all carbapenem prescriptions before dispensing*
- **Pre-authorization** by microbiology can lead to **critical delays** in initiating life-saving broad-spectrum antibiotics, especially for patients presenting with **sepsis** or severe infections in the Emergency Department.
- While it controls initial prescribing, it does not adequately address the issue of **prolonged or unreviewed therapy** once the prescription has been approved and started.
*Removing carbapenems from the hospital formulary*
- **Removing carbapenems** from the formulary is an **extreme measure** that eliminates essential treatment options for severe infections caused by **Extended-Spectrum Beta-Lactamase (ESBL)**-producing organisms or other **multi-drug resistant (MDR)** pathogens.
- This approach would leave clinicians without vital tools for managing complex infections, potentially increasing **morbidity and mortality** rather than promoting judicious use.
*Implementing educational sessions on carbapenem indications for Emergency Department staff*
- While **education** is a foundational element of antimicrobial stewardship, it is often **insufficient alone** to significantly alter entrenched prescribing behaviors or achieve rapid, substantial reductions in inappropriate use.
- This intervention only targets the **Emergency Department**, neglecting the significant portion of inappropriate carbapenem use (24%) identified from **unreviewed continuations** during ICU step-down.
Question 56: A 58-year-old woman presents to the Emergency Department with a 30-hour history of a painful, swollen, erythematous right calf. She has type 2 diabetes treated with metformin. Temperature is 38.2°C, heart rate 98 bpm, blood pressure 135/82 mmHg. The affected area measures 18 cm × 12 cm with a clearly demarcated edge and is tender to touch. There is no crepitus, no blistering, and no systemic signs of sepsis. Blood tests show WCC 13.2 × 10⁹/L, CRP 78 mg/L, creatinine 82 μmol/L. What is the most appropriate antibiotic choice?
A. Oral flucloxacillin (Correct Answer)
B. Intravenous flucloxacillin and clindamycin
C. Oral co-amoxiclav
D. Intravenous piperacillin-tazobactam, clindamycin and gentamicin
E. Oral doxycycline
Explanation: ***Oral flucloxacillin***- This patient presents with uncomplicated **cellulitis/erysipelas** categorized as **Eron Class II** (stable with single comorbidity but stable vitals), for which oral therapy is first-line.- **Flucloxacillin** provides excellent narrow-spectrum coverage for the most common causative organisms, **Staphylococci** and **Streptococci**, and the patient has no signs of severe sepsis or impaired absorption.*Intravenous flucloxacillin and clindamycin*- **Intravenous** administration is reserved for **Eron Class III or IV** patients who exhibit significant systemic upset, instability, or rapidly progressing infection.- The addition of **clindamycin** is typically used in suspected **toxic shock syndrome** or necrotizing infections to inhibit toxin production, which is not indicated here.*Oral co-amoxiclav*- **Co-amoxiclav** is a broad-spectrum antibiotic that is usually reserved for **bite wounds**, facial cellulitis, or infections where **Gram-negative** or anaerobic coverage is specifically required.- It is not recommended as first-line for simple limb cellulitis to avoid unnecessary broad-spectrum use and the risk of **Clostridioides difficile**.*Intravenous piperacillin-tazobactam, clindamycin and gentamicin*- This intensive combination therapy is designated for **life-threatening infections** such as **necrotizing fasciitis** or severe hospital-acquired sepsis.- Clinical features like the **clearly demarcated edge** and absence of **crepitus** or disproportionate pain rule out the need for such aggressive, multi-drug IV coverage.*Oral doxycycline*- **Doxycycline** is primarily used as an alternative for cellulitis in patients with a confirmed **penicillin allergy**.- It is not the preferred first-line agent because **flucloxacillin** is generally more effective against the **beta-hemolytic streptococci** frequently responsible for these presentations.
Question 57: A hospital trust implements a new antimicrobial stewardship initiative using intravenous-to-oral switch protocols for patients on IV antibiotics who meet specific criteria: afebrile for 24 hours, improving clinically, able to swallow, and functioning gastrointestinal tract. After 6 months, audit data shows that the median duration of IV therapy has decreased from 5.5 days to 3.2 days, with no increase in treatment failures or readmissions. What is the primary benefit of this intervention in terms of antimicrobial stewardship principles?
A. Reduction in antimicrobial resistance rates
B. Decreased risk of catheter-related bloodstream infections and reduced length of hospital stay (Correct Answer)
C. Improved bioavailability of antibiotics
D. Lower overall antibiotic consumption
E. Enhanced penetration of antibiotics into infected tissues
Explanation: ***Decreased risk of catheter-related bloodstream infections and reduced length of hospital stay***- Switching from **intravenous (IV)** to **oral (PO)** therapy eliminates the need for vascular access, thereby reducing the incidence of **catheter-related bloodstream infections (CRBSI)** and thrombophlebitis.- It facilitates earlier **hospital discharge**, as patients no longer require inpatient nursing care for IV administration, leading to lower healthcare costs and improved patient mobility.*Reduction in antimicrobial resistance rates*- While stewardship aims to reduce resistance, switching from IV to PO using the same agent does not change the **selection pressure** exerted on bacterial populations.- Resistance rates are more closely linked to the **spectrum of activity** and the total **duration of therapy**, rather than solely the route of administration.*Improved bioavailability of antibiotics*- Bioavailability refers to the fraction of a drug that reaches systemic circulation; **intravenous** administration inherently provides **100% bioavailability**.- Oral therapy may have equal (e.g., **linezolid**, **metronidazole**) but never higher bioavailability than the equivalent IV dose of the same drug.*Lower overall antibiotic consumption*- This intervention focuses on the **route of delivery** rather than the total amount of antibiotic used; the total **course duration** usually remains unchanged.- Stewardship strategies that reduce consumption typically involve **shortening therapy duration** or employing **watchful waiting** protocols.*Enhanced penetration of antibiotics into infected tissues*- Tissue penetration is a pharmacokinetic property determined by the drug's lipid solubility and molecular size, not the **route of entry** into the bloodstream.- While IV administration achieves higher **peak plasma concentrations (Cmax)** initially, the oral route is not inherently superior for tissue penetration when an equivalent dose is given.
Question 58: A 33-year-old woman who keeps pet reptiles presents with a 5-day history of multiple painful nodules on her shins that have not ulcerated. She also reports fever, malaise, and joint pains. The nodules are tender, erythematous, raised, and located on the anterior shins bilaterally without ulceration. What is the most likely diagnosis and appropriate initial investigation?
A. Sporotrichosis – skin biopsy for fungal culture
B. Erythema nodosum – chest X-ray and tuberculosis screening (Correct Answer)
C. Cutaneous tuberculosis – skin biopsy for mycobacterial culture
D. Nocardiosis – skin biopsy and modified acid-fast stain
E. Cellulitis – blood cultures and soft tissue ultrasound
Explanation: ***Erythema nodosum – chest X-ray and tuberculosis screening*** - The patient presents with classic **erythema nodosum (EN)**, characterized by tender, erythematous, **non-ulcerating nodules** on the anterior shins accompanied by systemic symptoms like fever and **arthralgia**. - Initial management involves screening for common underlying triggers such as **sarcoidosis** or **tuberculosis** via a **chest X-ray** and IGRA/Mantoux test.*Sporotrichosis – skin biopsy for fungal culture* - **Sporotrichosis** typically presents with a **lymphocutaneous spread**, manifesting as a chain of nodules along lymphatic drainage lines that frequently **ulcerate**. - While exposure to plants or soil is common, the bilateral, non-ulcerating shin distribution described here is more representative of systemic **panniculitis**.*Cutaneous tuberculosis – skin biopsy for mycobacterial culture* - Primary **cutaneous tuberculosis** (like lupus vulgaris) usually presents as indolent, **asymmetric plaques or ulcers** rather than multiple acute, tender nodules on the shins. - While TB can trigger **reactive EN**, the primary cutaneous infection itself lacks the classic rapid-onset bilateral shin distribution seen in this case.*Nocardiosis – skin biopsy and modified acid-fast stain* - **Nocardiosis** typically affects **immunocompromised** individuals and presents as localized abscesses or **cellulitic lesions** that may drain fluid. - It does not characteristically present as sterile, symmetrical, tender nodules isolated to the anterior shins.*Cellulitis – blood cultures and soft tissue ultrasound* - **Cellulitis** is usually **unilateral**, poorly demarcated, and involves spreading skin warmth and edema rather than discrete, multiple **raised nodules**. - The bilateral involvement of the shins and the specific nodular appearance are almost always indicative of a **reactive panniculitis** like EN rather than a primary bacterial skin infection.
Question 59: A hospital antimicrobial stewardship committee is reviewing strategies to reduce healthcare-associated Clostridioides difficile infections (CDI), which have increased by 30% over the past year. Analysis shows that most cases follow treatment with broad-spectrum antibiotics, particularly co-amoxiclav, cephalosporins, and fluoroquinolones. Which of the following interventions would most effectively reduce CDI incidence based on current evidence?
A. Universal prescribing of probiotics alongside all broad-spectrum antibiotics
B. Implementing an automatic stop order for all antibiotics after 7 days
C. Restricting use of high-risk antibiotics (particularly cephalosporins, co-amoxiclav, and fluoroquinolones) and promoting narrow-spectrum alternatives (Correct Answer)
D. Routine screening of all admitted patients for C. difficile colonisation
E. Mandatory use of fidaxomicin instead of vancomycin for all CDI treatment
Explanation: ***Restricting use of high-risk antibiotics (particularly cephalosporins, co-amoxiclav, and fluoroquinolones) and promoting narrow-spectrum alternatives***- Reducing exposure to **high-risk antibiotics** (the "Four Cs": Cephalosporins, Co-amoxiclav, Clindamycin, and Quinolones) is the most effective evidence-based strategy for preventing **C. difficile infection (CDI)**.- **Antimicrobial stewardship** interventions that promote **narrow-spectrum alternatives** preserve the protective intestinal microbiota and significantly decrease hospital CDI rates.*Universal prescribing of probiotics alongside all broad-spectrum antibiotics*- Current clinical guidelines do not provide sufficient evidence to support the **routine use of probiotics** for the primary prevention of CDI in a hospital setting.- There are concerns regarding the **quality of evidence** and the risk of rare complications like **fungemia or bacteremia** in immunocompromised patients.*Implementing an automatic stop order for all antibiotics after 7 days*- This approach is often too arbitrary and may lead to **inappropriate treatment durations** for infections that require longer courses, such as endocarditis or osteomyelitis.- While reducing duration is helpful, it does not specifically address the **risk profile of the drug classes** being used, which is a stronger driver of CDI.*Routine screening of all admitted patients for C. difficile colonisation*- Screening for **asymptomatic colonization** is not routinely recommended as it does not distinguish between colonization and active disease and can lead to **unnecessary treatment**.- This intervention focuses on identification rather than **preventing the primary disruption** of gut flora that leads to infection.*Mandatory use of fidaxomicin instead of vancomycin for all CDI treatment*- While **fidaxomicin** is associated with lower rates of **recurrence** compared to vancomycin, it is a treatment strategy rather than a primary prevention strategy.- Changing the treatment of existing cases does not reduce the **initial incidence** of CDI caused by broad-spectrum antibiotic use in the general patient population.
Question 60: A 69-year-old man with compensated liver cirrhosis (Child-Pugh B) due to alcohol-related liver disease presents with a 2-day history of a painful, rapidly spreading erythematous rash on his right leg after paddling in seawater at the beach. Examination reveals a haemorrhagic bullous cellulitis extending from ankle to knee. Temperature is 38.9°C, BP 108/68 mmHg, and heart rate 102 bpm. Which pathogen is most likely responsible and what is the appropriate antibiotic therapy?
A. Aeromonas hydrophila – intravenous ciprofloxacin and doxycycline
B. Vibrio vulnificus – intravenous ceftriaxone and doxycycline (Correct Answer)
C. Streptococcus pyogenes – intravenous benzylpenicillin and clindamycin
D. Pseudomonas aeruginosa – intravenous piperacillin-tazobactam
E. Staphylococcus aureus – intravenous flucloxacillin
Explanation: ***Vibrio vulnificus – intravenous ceftriaxone and doxycycline***
- **Vibrio vulnificus** is a halophilic bacterium found in **warm seawater**; patients with **liver cirrhosis** are at high risk for fulminant sepsis and **haemorrhagic bullous cellulitis**.
- The recommended definitive treatment is a combination of a **third-generation cephalosporin** (like ceftriaxone) and **doxycycline** to cover this aggressive gram-negative pathogen.
*Aeromonas hydrophila – intravenous ciprofloxacin and doxycycline*
- While it presents similarly with necrotizing skin infections, **Aeromonas** is classically associated with **freshwater** exposure rather than seawater.
- Although the antibiotic coverage is similar, the **environmental context** of the beach specifically points toward Vibrio species.
*Streptococcus pyogenes – intravenous benzylpenicillin and clindamycin*
- **Streptococcus pyogenes** is the leading cause of non-bullous cellulitis and necrotizing fasciitis, but it lacks a specific association with **seawater exposure**.
- While clindamycin is used for its anti-toxin effects in necrotizing infections, this regimen lacks the necessary coverage for **marine gram-negative bacilli**.
*Pseudomonas aeruginosa – intravenous piperacillin-tazobactam*
- **Pseudomonas** is typically associated with hot tubs, puncture wounds through sneakers, or burns, rather than general seawater exposure in a cirrhotic patient.
- While piperacillin-tazobactam has broad activity, it is not the **first-line specific recommendation** for the characteristic bullous lesions of Vibrio.
*Staphylococcus aureus – intravenous flucloxacillin*
- **Staphylococcus aureus** causes common skin infections and abscesses but does not typically present as **rapidly spreading haemorrhagic bullae** triggered by seawater.
- **Flucloxacillin** is ineffective against the gram-negative marine organisms that are the primary concern in this specific clinical scenario.
